Prima BioMed Ltd ; ; is pleased to announce that the Korean Ministry of Food and Drug Safety has granted approval to start the CANVAS trial at several clinical sites in Korea. The Company expects ...

Prima BioMed Ltd is pleased to announce that it has commenced recruitment of patients into the CANVAS trial in Europe. Prima has authorized several centers in Ukraine to start enrolling patients.

Prima BioMed Ltd today released its quarterly Shareholder Newsletter available on the company website at http://primabiomed.com.au/investor/investor_update.php.

is pleased to announce that the Korean Ministry of Food and Drug Safety has granted approval to start the CANVAS trial at several clinical sites in Korea. The Company expects that sites in Korea ...